INTRODUCTION AND AIMS:
The diagnosis and differentiation of the subtypes of chronic kidney disease -mineral and bone disorder (CKD-MBD) are challenging. The golden standard of diagnosis is bone biopsy, but it is invasive and not available in every center. 18 Fluorine isotope is a PET-tracer, which incorporates into the bone at sites of high metabolic activity, triggered by osteoblast and osteoclast activity. The aim of this study is to evaluate if 18 F-PET imaging correlates with the metabolic activity of bone in dialysis patients, as assessed by the histomorphometry of bone biopsy. METHODS: 21 dialysis patients underwent a dynamic 18 F-positron-emission-tomography (PET) -scan (L1-L4) and a bone biopsy. The bone biopsy was taken from the iliac spine vertically after double labelling with tetracycline within one month after the PETscan. The PET-scan was analyzed using graphical Patlak model and K i was measured. K i is the bone plasma clearance of 18 Fluor, which reflects 18 Fluor activity in the bone. As histomorphometrics parameters to detect metabolic activity in bone we used BFR (bone formation rate) ¼ mineral apposition rate (MAR) x mineralizing surface/bone surface (MS/BS), Oc.S/BS (osteoclast surface/bone surface), ES/BS (erosion surface/ bone surface) and Ob.S/BS (osteoblast surface/bone surface) RESULTS: As shown in Figure1 , and cardiac valve calcification (CVC) were assessed at baseline and 2-year follow-up. CAC were assessed using the Agatston score measured by electron beam computed tomography or multidetector computed tomography. AAC was assessed by plain lateral lumbar radiograph using the Kauppila score. CVC was measured by echocardiography. Progression was defined by comparing VC images at baseline with those at 2-year. When CAC/AAC scores of 2-year were greater than those of baseline, CAC/AAC were considered .05). Radius trabecular bone was also less connected (p<0.01) in WKT, with no difference between groups at the tibia. Serum levels of phosphate, PTH and 25-OH-D3 were higher in WKT than in CT. 2-Females: Female groups were similar for age (58 [53-63] in WKT vs 59 [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] in CT) and postmenopausal status (75 vs 79%). WKT had dramatically more prevalent osteoporotic fractures than CT (32 vs 4%, p<0.01). BMI was lower in vs 27 (24-29), p<0.02]. FRAX-MOF was higher in WKT [4.8 (3.4-6.7) vs 3.6% (2.6-4.6), p¼0.03], while the FRAX-Hip score did not differ between groups. On average, aBMD was similar between groups at both spine and hip sites (hip: 0.7960.15 vs 0.7660.10 g/cm 2 ) but 29% of WKT had a hip Tscore <-2.5. Cortical and trabecular vBMD were significantly lower in WKT than in CT (radius Total vBMD 245mg/cm3 [207-300] vs 306mg/cm 3 [260-347], p<0.03). Cortical and trabecular area or cortical thickness at both sites were similar between groups. Unexpectedly, tibia cortical porosity was lower in WKT than in p<0.01). Trabecular Bone Volume was lower at both sites in WKT (Tibia BV/ TV: 1063 vs 1363%, p<0.01). Fractured WKT trended to higher serum PTH levels, [212 pg/ml (140-300) vs 100 (72-210), p¼0.07]. Neither aBMD nor HR-pQCT parameters were discriminant. Patients with previous KT history had worse bone status. CONCLUSIONS: Osteoporosis in CKD5 is gender specific and combines structural trabecular bone degradation and hypomineralization of both cortical and trabecular bone compartments, that are not detected by DXA. were assessed using the Agatston score measured by electron beam computed tomography or multi-detector computed tomography; abdominal aortic calcification (AAC) was assessed by plain lateral lumbar radiograph using the Kauppila score; cardiac valve calcification (CVC) was measured by echocardiography. Total vascular calcification was defined as confirmed presence of vascular calcification in 1 location (CAC, AAC or CVC). RESULTS: 1493 eligible patients who had at least one of the three calcification evaluation images at baseline were defined as the FAC population. FAC patients were 59.5% males. The mean age were 50.2 6 12.53 years, and the mean dialysis vintage were 4.6 6 3.78 years. 1217 FAC patients completed the 2-year follow-up. At 2-year follow-up, the all-cause mortality, cardiovascular mortality and non-fatal cardiovascular events were significantly higher in FAC patients with presence of baseline total vascular calcification compared to patients with absence of vascular calcification (7.2% vs 1.2%, p<0.001; 5.4% vs 1.2%, p¼0.001; 2.5% vs 0.0%, p¼0.003). Kaplan-Meier analysis further revealed significant differences in all-cause mortality between patients with presence and absence of baseline total vascular calcification, coronary artery calcification, abdominal aortic calcification or cardiac valve calcification.
